SLC17A4
Probable small intestine urate exporter
Also known as: KIAA2138, S17A4_HUMAN
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q9Y2C5
- Gene
- SLC17A4
- Ensembl
- ENSG00000146039
- Chromosome
- 6
- Canonical length
- 497 aa
- Protein class
- Metabolic proteins, Predicted membrane proteins, Transporters
OverviewNCBI Gene
Phosphate homeostasis is maintained by regulating intake, intestinal absorption, bone deposition and resorption, and renal excretion of phosphate. The central molecule in the control of phosphate excretion from the kidney is the sodium/phosphate cotransporter NPT1 (SLC17A1; MIM 182308), which is located in the renal proximal tubule. NPT1 uses the transmembrane electrochemical potential gradient of sodium to transport phosphate across the cell membrane. SLC17A4 is a similar sodium/phosphate cotransporter in the intestinal mucosa that plays an important role in the absorption of phosphate from the intestine (summary by Shibui et al., 1999 [PubMed 10319585]).[supplied by OMIM, Feb 2011]
Canonical amino-acid sequenceUniProt
497 residues, UniProt reviewed canonical sequence.
>Q9Y2C5|SLC17A4
1 MSTGPDVKAT VGDISSDGNL NVAQEECSRK GFCSVRHGLA LILQLCNFSI YTQQMNLSIA
61 IPAMVNNTAP PSQPNASTER PSTDSQGYWN ETLKEFKAMA PAYDWSPEIQ GIILSSLNYG
121 SFLAPIPSGY VAGIFGAKYV VGAGLFISSF LTLFIPLAAN AGVALLIVLR IVQGIAQVMV
181 LTGQYSIWVK WAPPLERSQL TTIAGSGSML GSFIVLLAGG LLCQTIGWPY VFYIFGGIGC
241 ACCPLWFPLI YDDPVNHPFI SAGEKRYIVC SLAQQDCSPG WSLPIRAMIK SLPLWAILVS
301 YFCEYWLFYT IMAYTPTYIS SVLQANLRDS GILSALPFVV GCICIILGGL LADFLLSRKI
361 LRLITIRKLF TAIGVLFPSV ILVSLPWVRS SHSMTMTFLV LSSAISSFCE SGALVNFLDI
421 APRYTGFLKG LLQVFAHIAG AISPTAAGFF ISQDSEFGWR NVFLLSAAVN ISGLVFYLIF
481 GRADVQDWAK EQTFTHLLocalizationUniProt · AlphaFold · HPA
Whether an antibody against SLC17A4 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Cell surface
- Secreted
- No
- Transmembrane segments
- 10
- Mean surface accessibility (rSASA)
- 0.28
- Highest tissue expression
- 48 nTPM
Expression across tissuesHPA
Tissue
- liver: 48 nTPM
- small intestine: 30 nTPM
- duodenum: 27 nTPM
- rectum: 25 nTPM
- pancreas: 21 nTPM
- colon: 19 nTPM
Single-cell type
- cholangiocytes: 170 nCPM
- colonocytes: 156 nCPM
- enterocytes: 83 nCPM
- hepatocytes: 73 nCPM
- pancreatic duct cells: 57 nCPM
- goblet cells: 34 nCPM
Immune cell
- neutrophil: 0.1 nTPM
- basophil: 0 nTPM
- classical monocyte: 0 nTPM
- eosinophil: 0 nTPM
- gdT-cell: 0 nTPM
- intermediate monocyte: 0 nTPM
Brain region
- cerebellum: 1.5 nTPM
- pons: 0.6 nTPM
- cerebral cortex: 0.4 nTPM
- hippocampal formation: 0.3 nTPM
- hypothalamus: 0.3 nTPM
- white matter: 0.3 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 1.08
- gnomAD pLI
- 0
- gnomAD missense Z
- 0.09
- DepMap mean gene effect
- 0.03
- DepMap dependency class
- none
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 3% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- phosphate-containing compound metabolic process
- sodium ion transport
- sodium-dependent phosphate transport
Molecular functions
- sodium:phosphate symporter activity
- thyroid hormone transmembrane transporter activity
- transmembrane transporter activity
- urate transmembrane transporter activity
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads SLC17A4 as an antibody target. Whether an autoantibody or antibody against SLC17A4 could matter depends on whether native SLC17A4 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
SLC17A4 is annotated at the cell surface, where native SLC17A4 is exposed to circulating antibodies and is a prime autoantibody target that could block, deplete, or overstimulate it.
Annotation status
The present source text does not explicitly label SLC17A4 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...